Cargando…
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)
PURPOSE: To evaluate local and systemic safety of suprachoroidal (SC) triamcinolone acetonide injectable suspension (CLS-TA) injections in subjects with non-infectious uveitis (NIU). DESIGN: Open-label, prospective multicentre safety study. PARTICIPANTS: Thirty-eight subjects with NIU, with and with...
Autores principales: | Henry, Christopher Ryan, Shah, Milan, Barakat, Mark R, Dayani, Pouya, Wang, Robert C, Khurana, Rahul N, Rifkin, Lana, Yeh, Steven, Hall, Colette, Ciulla, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132856/ https://www.ncbi.nlm.nih.gov/pubmed/33547034 http://dx.doi.org/10.1136/bjophthalmol-2020-318019 |
Ejemplares similares
-
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)
por: Khurana, Rahul N, et al.
Publicado: (2022) -
CLs
Publicado: (1998) -
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE
por: Singer, Michael A., et al.
Publicado: (2021) -
Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders
por: Wan, Chen-rei, et al.
Publicado: (2020) -
Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
por: Kansara, Viral, et al.
Publicado: (2020)